On Monday, Ocular Therapeutix Inc (NASDAQ: OCUL) opened lower -3.86% from the last session, before settling in for the closing price of $11.41. Price fluctuations for OCUL have ranged from $5.78 to $13.85 over the past 52 weeks.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 8.51%. Company’s average yearly earnings per share was noted -20.81% at the time writing. With a float of $177.51 million, this company’s outstanding shares have now reached $211.90 million.
Ocular Therapeutix Inc (OCUL) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Ocular Therapeutix Inc is 16.23%, while institutional ownership is 65.15%. The most recent insider transaction that took place on Oct 02 ’25, was worth 106,473. In this transaction Chief Development Officer of this company sold 9,653 shares at a rate of $11.03, taking the stock ownership to the 194,440 shares. Before that another transaction happened on Oct 02 ’25, when Company’s Chief Scientific Officer sold 10,502 for $11.04, making the entire transaction worth $115,942. This insider now owns 249,409 shares in total.
Ocular Therapeutix Inc (OCUL) Latest Financial update
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.22 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -0.21) by -0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.36 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -20.81% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 2.49% during the next five years compared to 8.51% growth over the previous five years of trading.
Ocular Therapeutix Inc (NASDAQ: OCUL) Trading Performance Indicators
Check out the current performance indicators for Ocular Therapeutix Inc (OCUL). In the past quarter, the stock posted a quick ratio of 10.02. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 41.03.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.28, a number that is poised to hit -0.37 in the next quarter and is forecasted to reach -1.40 in one year’s time.
Technical Analysis of Ocular Therapeutix Inc (OCUL)
The latest stats from [Ocular Therapeutix Inc, OCUL] show that its last 5-days average volume of 6.49 million was superior to 1.99 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 22.08%.
During the past 100 days, Ocular Therapeutix Inc’s (OCUL) raw stochastic average was set at 59.78%, which indicates a significant increase from 14.53% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.73 in the past 14 days, which was higher than the 0.55 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $12.27, while its 200-day Moving Average is $9.21. Now, the first resistance to watch is $11.51. This is followed by the second major resistance level at $12.06. The third major resistance level sits at $12.39. If the price goes on to break the first support level at $10.64, it is likely to go to the next support level at $10.31. The third support level lies at $9.76 if the price breaches the second support level.
Ocular Therapeutix Inc (NASDAQ: OCUL) Key Stats
There are currently 173,995K shares outstanding in the company with a market cap of 2.32 billion. Presently, the company’s annual sales total 63,720 K according to its annual income of -193,510 K. Last quarter, the company’s sales amounted to 13,460 K and its income totaled -67,810 K.
